Borderline Personality Disorder Questions & Answers

1. Linehan MM, Heard HL, Armstrong HE. Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients [published erratum appears in Arch Gen Psychiatry 1994 May;51(5):422]. Arch Gen Psychiatry. 1993 Dec. 50(12):971-4. [QxMD MEDLINE Link].

2. Linehan MM, Tutek DA, Heard HL, Armstrong HE. Interpersonal outcome of cognitive behavioral treatment for chronically suicidal borderline patients. Am J Psychiatry. 1994 Dec. 151(12):1771-6. [QxMD MEDLINE Link].

3. Pine F. A working nosology of borderline syndromes in children. The Borderline Child. New York, NY: McGraw Hill; 1982. 83.

4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. 5th ed. Arlington, VA: American Psychiatric Association; 2013. 663-6.

5. Sansone RA, Sansone LA. The Relationship Between Borderline Personality and Obesity. Innov Clin Neurosci. 2013 Apr. 10(4):36-40. [QxMD MEDLINE Link]. [Full Text].

6. Bernhardt K, Friege L, Gerok-Falke K, Aldenhoff JB. [In-patient treatment concept for acute crises of borderline patients on the basis of dialectical-behavioral therapy]. Psychother Psychosom Med Psychol. 2005 Sep. 55(9-10):397-404. [QxMD MEDLINE Link].

7. Hanson G, Bemporad JR, Smith HF, Chicchetti D. The day and residential treatment of the borderline child. The Borderline Child. New York, NY: McGraw Hill; 1982. 235.

8. Bohus MJ, Landwehrmeyer GB, Stiglmayr CE, et al. Naltrexone in the treatment of dissociative symptoms in patients with borderline personality disorder: an open-label trial. J Clin Psychiatry. 1999 Sep. 60(9):598-603. [QxMD MEDLINE Link].

9. Schroeder K, Fisher HL, Schäfer I. Psychotic symptoms in patients with borderline personality disorder: prevalence and clinical management. Curr Opin Psychiatry. 2013 Jan. 26 (1):113-9. [QxMD MEDLINE Link].

10. Deutsch H. Some forms of emotional disturbance and their relationship to schizophrenia. 1942. Psychoanal Q. 2007 Apr. 76(2):325-44; discussion 345-86. [QxMD MEDLINE Link].

11. Kernberg OF. Borderline Conditions and Pathological Narcissism. New York, NY: Aronson; 1975.

12. Marcus J, Ovsiew F, Hans S. Neurological dysfunction in borderline children. The Borderline Child. New York, NY: McGraw Hill; 1982. 171.

13. De la Fuente JM, Tugendhaft P, Mavroudakis N. Electroencephalographic abnormalities in borderline personality disorder. Psychiatry Res. 1998 Feb 9. 77(2):131-8. [QxMD MEDLINE Link].

14. Baird AA, Veague HB, Rabbitt CE. Developmental precipitants of borderline personality disorder. Dev Psychopathol. 2005 Fall. 17(4):1031-49. [QxMD MEDLINE Link].

15. Mahler M, Ross J, Defries Z. Clinical studies in benign and malignant cases of childhood psychosis. Am J Orthopsychiatry. 1949. 19:295.

16. Combrinck-Graham L. The borderline syndrome in childhood: a family systems approach. J Psychother Fam. 1989. 5:31-34.

17. Clarkin JF, Widiger TA, Frances A, et al. Prototypic typology and the borderline personality disorder. J Abnorm Psychol. 1983 Aug. 92(3):263-75. [QxMD MEDLINE Link].

18. Ørts Clemmensen LM1, Olrik Wallenstein Jensen S, Zanarini MC, Skadhede S, Munk-Jørgensen P. Changes in treated incidence of borderline personality disorder in denmark: 1970-2009. Can J Psychiatry. 2013. 58(9):522-8.

19. Nasiri H, Abedi A, Ebrahimi A, Ameli SS, Samouei R. Personality profile of women affected with borderline personality disorder. Mater Sociomed. 2013. 25(1):60-3. [QxMD MEDLINE Link]. [Full Text].

20. Links PS, Heslegrave R, van Reekum R. Prospective follow-up study of borderline personality disorder: prognosis, prediction of outcome, and Axis II comorbidity. Can J Psychiatry. 1998 Apr. 43(3):265-70. [QxMD MEDLINE Link].

21. Andrulonis PA. Paper presented at: Annual Meeting of the American Psychiatric Association. Borderline personality subcategories in children. 1990.

22. Zimmerman M, Mattia JI. Axis I diagnostic comorbidity and borderline personality disorder. Compr Psychiatry. 1999 Jul-Aug. 40(4):245-52. [QxMD MEDLINE Link].

23. Weil A. Certain severe disturbances of ego development in children. Psychoanal Study Child. 1953. 8:271.

24. Freud A. The assessment of borderline cases. The Writings of Anna Freud. New York, NY: International Universities Press; 1969. Vol 5:

25. Schuermann B, Kathmann N, Stiglmayr C, Renneberg B, Endrass T. Impaired decision making and feedback evaluation in borderline personality disorder. Psychol Med. 2011 Sep. 41(9):1917-27. [QxMD MEDLINE Link].

26. Block MJ, Westen D, Ludolph P, et al. Distinguishing female borderline adolescents from normal and other disturbed female adolescents. Psychiatry. 1991 Feb. 54(1):89-103. [QxMD MEDLINE Link].

27. Skodol AE, Grilo CM, Keyes KM, Geier T, Grant BF, Hasin DS. Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample. Am J Psychiatry. 2011 Mar. 168(3):257-64. [QxMD MEDLINE Link].

28. Marsha M. Linehan PhD. DBT® Skills Training Manual, Second Edition. Guilford; 2014.

29. Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry. 2015 May. 72 (5):475-82. [QxMD MEDLINE Link].

30. Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. 2006 Jan. 163(1):41-7. [QxMD MEDLINE Link]. [Full Text].

31. McClellan J, Sikich L, Findling RL, et al. Treatment of early-onset schizophrenia spectrum disorders (TEOSS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry. 2007 Aug. 46(8):969-78. [QxMD MEDLINE Link].

32. Meighen KG, Hines LA, Lagges AM. Risperidone treatment of preschool children with thermal burns and acute stress disorder. J Child Adolesc Psychopharmacol. 2007 Apr. 17(2):223-32. [QxMD MEDLINE Link].

33. Armenteros JL, Lewis JE, Davalos M. Risperidone augmentation for treatment-resistant aggression in attention-deficit/hyperactivity disorder: a placebo-controlled pilot study. J Am Acad Child Adolesc Psychiatry. 2007 May. 46(5):558-65. [QxMD MEDLINE Link].

34. White T, Schultz SK. Naltrexone treatment for a 3-year-old boy with self-injurious behavior. Am J Psychiatry. 2000 Oct. 157(10):1574-82. [QxMD MEDLINE Link].

35. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Time to attainment of recovery from borderline personality disorder and stability of recovery: A 10-year prospective follow-up study. Am J Psychiatry. 2010 Jun. 167(6):663-7. [QxMD MEDLINE Link].

36. Gunderson JG, Stout RL, McGlashan TH, et al. Ten-year course of borderline personality disorder: psychopathology and function from the collaborative longitudinal personality disorders study. Arch Gen Psychiatry. 2011 Aug. 68(8):827-37. [QxMD MEDLINE Link]. [Full Text].

37. Feliu-Soler A, Pascual JC, Borràs X, Portella MJ, Martín-Blanco A, Armario A, et al. Effects of Dialectical Behaviour Therapy-Mindfulness Training on Emotional Reactivity in Borderline Personality Disorder: Preliminary Results. Clin Psychol Psychother. 2013 Mar 14. [QxMD MEDLINE Link].

38. Thomsen MS Ruocco AC, Uliaszek AA Mathiesen BB1, Simonsen E. Changes in Neurocognitive Functioning After 6 Months of Mentalization-Based Treatment for Borderline Personality Disorder. J Pers Disord. 2016. 1-19.

Roy H Lubit, MD, PhD Private Practice

Roy H Lubit, MD, PhD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry

Disclosure: Nothing to disclose.

Caroly Pataki, MD Health Sciences Clinical Professor of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, David Geffen School of Medicine

Caroly Pataki, MD is a member of the following medical societies: American Academy of Child and Adolescent Psychiatry, New York Academy of Sciences, Physicians for Social Responsibility

Disclosure: Nothing to disclose.

Elizabeth A Finley-Belgrad, MD Clinical Assistant Professor, Department of Psychiatry, Northeastern Ohio Universities College of Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article